Home Mainstay Medical International plc

Mainstay Medical International plc

Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain

ReActiv8 is designed to be a restorative treatment and represents a new option for patients suffering with chronic low back pain.

Mainstay Medical to Present at the Deutsche Bank 42nd Annual Health Care Conference

Mainstay Medical International plc (“Mainstay” or the “Company”, Euronext Paris: MSTY.PA and ESM of the Irish Stock...